Glasgow’s universities have played a key role in the creation of the NHS Louisa Jordan, Scotland’s largest temporary hospital based in the Scottish Events Campus (SEC) in Glasgow.
Impressive collaboration was required across the project – from the designers, to procurement, to clinical modelling. All of which was person-centred and connected to the core values of the NHS across Scotland.
Researchers at the University of Strathclyde applied their data modelling expertise to help NHS Lanarkshire predict and manage demand for intensive care unit beds during the Covid-19 pandemic. The Strathclyde team was able to accurately predict that the intense pressure from COVID-19 would reach a peak during the first two weeks of April and that enough critical care and other beds were available to cope with this. The effective use of the Strathclyde model has received significant recognition across NHS Scotland and the Scottish Government.
Digital technology has been used to transform patient care this past year at NHS Greater Glasgow and Clyde (NHSGGC) and two projects have been recognised for leading the field in Scotland. The COVID-19 Response Award was given to the vCreate Video Service Team which has helped to keep patients and their loved ones connected throughout the past year.
The use of Video Diaries created by hospital staff and shared with families was first piloted by the Royal Hospital for Children’s Neonatal team and now widely used across critical care teams throughout the UK and overseas. vCreate’s Clinical Video Service has also transformed care by allowing video consultations to be conducted remotely, keeping patients and staff safe in the face of COVID-19.
The University of Glasgow is part of a major UK research study into the long-term health impacts of COVID-19 on hospitalised patients has been launched. The PHOSP-COVID study was awarded £8.4million jointly by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR).
The University of Glasgow shares expertise with a national consortium of leading researchers and clinicians from across the UK to assess the impact of COVID-19 on patients’ health and their recovery. Around 10,000 patients are expected to take part in the study making it one of the largest comprehensive studies in the world to understand and improve the health of survivors after hospitalisation from COVID-19.
A new clinical trial to determine whether a third dose of vaccine will improve the immune response for people who have weakened immune systems is launching in the UK.
The £2.2 million study will build on the OCTAVE trial, led by the University of Glasgow and co-ordinated by the University of Birmingham’s Cancer Research UK Clinical Trials Unit.
Additional News Stories
If you would like to reach out to discuss anything from the above case study, please get in touch.
Let us know if you would like to discuss contributing to the case studies we currently profile.